Takeda updates share repurchase program, acquires 4.5m shares

Takeda Pharmaceutical (TSE:4502) today announced an update on its share repurchase program. Between March 1, 2025, and March 31, 2025, the company acquired 4,513,800 of its own shares at a total cost of JPY 20,144,679,100. These shares were repurchased on the open market through a trust bank. This buyback is part of a larger program, authorized on January 30, 2025, which allows for the acquisition of up to 28.5 million shares at a maximum cost of JPY 100 billion, running from February 17, 2025, to May 31, 2025. As of March 31, 2025, Takeda has acquired a total of 11,543,600 shares at a cost of JPY 49,977,908,700 under this program. The company cited the acquisition is in accordance with Article 459, paragraph 1 of the Companies Act of Japan.